CPEB1 | Cytoplasmic polyadenylation element binding protein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CTAG2 | Cancer/testis antigen 2 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CYB5R2 | Cytochrome b5 reductase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DEPDC1 | DEP domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
DFNB59 | Deafness, autosomal recessive 59 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
DIAPH3 | Diaphanous-related formin 3 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
DMC1 | DNA meiotic recombinase 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
DNAH7 | Dynein, axonemal, heavy chain 7 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
DNAJC18 | DnaJ (Hsp40) homolog, subfamily C, member 18 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DTL | Denticleless E3 ubiquitin protein ligase homolog (Drosophila) | Predicted intracellular proteins
| | | | | Tissue enhanced |
EFCAB13 | EF-hand calcium binding domain 13 | Predicted intracellular proteins
| | | | | Tissue enhanced |
EIF5A2 | Eukaryotic translation initiation factor 5A2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ELL3 | Elongation factor RNA polymerase II-like 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
EME1 | Essential meiotic structure-specific endonuclease 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
EN2 | Engrailed homeobox 2 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ENO4 | Enolase family member 4 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPHA6 | EPH receptor A6 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
EZH2 | Enhancer of zeste 2 polycomb repressive complex 2 subunit | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM106A | Family with sequence similarity 106, member A | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM169A | Family with sequence similarity 169, member A | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM184A | Family with sequence similarity 184, member A | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM53A | Family with sequence similarity 53, member A | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM71F2 | Family with sequence similarity 71, member F2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM83F | Family with sequence similarity 83, member F | Predicted intracellular proteins
| | | | | Tissue enhanced |
FBF1 | Fas (TNFRSF6) binding factor 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FIBCD1 | Fibrinogen C domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
GLB1L | Galactosidase, beta 1-like | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GLT1D1 | Glycosyltransferase 1 domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
GPC5 | Glypican 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GPR135 | G protein-coupled receptor 135 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GSG2 | Germ cell associated 2 (haspin) | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
HERC5 | HECT and RLD domain containing E3 ubiquitin protein ligase 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
HIST1H2AG | Histone cluster 1, H2ag | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2AK | Histone cluster 1, H2ak | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2BB | Histone cluster 1, H2bb | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2BJ | Histone cluster 1, H2bj | Predicted intracellular proteins
| | | | | Tissue enhanced |
HMMR | Hyaluronan-mediated motility receptor (RHAMM) | CD markers FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HYLS1 | Hydrolethalus syndrome 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
IL4I1 | Interleukin 4 induced 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
INHA | Inhibin, alpha | Predicted secreted proteins
| | | | | Tissue enhanced |
IPO4 | Importin 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ISYNA1 | Inositol-3-phosphate synthase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
KIF18A | Kinesin family member 18A | Predicted intracellular proteins
| | | | | Tissue enhanced |
KIF2C | Kinesin family member 2C | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
KLF17 | Kruppel-like factor 17 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
KLHL35 | Kelch-like family member 35 | Predicted intracellular proteins
| | | | | Tissue enhanced |
LNP1 | Leukemia NUP98 fusion partner 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
LRRC27 | Leucine rich repeat containing 27 | Predicted intracellular proteins
| | | | | Tissue enhanced |
LRRC37A | Leucine rich repeat containing 37A | Predicted membrane proteins
| | | | | Tissue enhanced |
LRRC37A3 | Leucine rich repeat containing 37, member A3 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |